BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23314159)

  • 1. The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
    Gabra N; Saliba I
    Otolaryngol Head Neck Surg; 2013 Apr; 148(4):642-7. PubMed ID: 23314159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endolymphatic duct blockage surgery vs. intratympanic steroids for treatment of refractory Ménière's disease.
    Saliba I; Dufour-Fournier C; Asmar MH
    Eur Arch Otorhinolaryngol; 2024 May; ():. PubMed ID: 38789850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic gentamicin treatment for Ménière's disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study.
    Bremer HG; van Rooy I; Pullens B; Colijn C; Stegeman I; van der Zaag-Loonen HJ; van Benthem PP; Klis SF; Grolman W; Bruintjes TD
    Trials; 2014 Aug; 15():328. PubMed ID: 25135244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylprednisolone versus Dexamethasone for Control of Vertigo in Patients with Definite Meniere's disease.
    Masoumi E; Dabiri S; Khorsandi Ashtiani MT; Erfanian R; Sohrabpour S; Yazdani N; Safaee A; Firouzifar M
    Iran J Otorhinolaryngol; 2017 Nov; 29(95):341-346. PubMed ID: 29383315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and preservation of hearing with low-dose gentamicin in unilateral meniere's disease: A clinical symptomatology-based study.
    Scarpa A; Avallone E; Carucci M; Salzano G; Chiarella G; Cassandro C; Viola P; Ricciardiello F; Ralli M; De Luca P; Salzano FA
    Am J Otolaryngol; 2024; 45(1):104116. PubMed ID: 37984050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere's Disease with Non-Serviceable Hearing.
    Thomas L; Lepcha A; Reka K; Augustine AM; Alex A; Philip A; Mammen MD
    Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):3738-3745. PubMed ID: 36742746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary Evidence for the Effects of Gentamicin on Vertical Semicircular Canals.
    Khan S; Quimby AE; Hwa TP; Bigelow DC; Brant J; Ruckenstein MJ
    ORL J Otorhinolaryngol Relat Spec; 2024; 86(2):89-94. PubMed ID: 38387448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic and surgical therapies for patients with Meniere's disease: A systematic review and network meta-analysis.
    Ahmadzai N; Cheng W; Kilty S; Esmaeilisaraji L; Wolfe D; Bonaparte J; Schramm D; Fitzpatrick E; Lin V; Skidmore B; Hutton B
    PLoS One; 2020; 15(9):e0237523. PubMed ID: 32870918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of repeated intratympanic gentamicin for Ménière's disease.
    Nguyen KD; Minor LB; Della Santina CC; Carey JP
    Laryngoscope; 2009 Apr; 119(4):792-8. PubMed ID: 19213044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic dexamethasone injections for refractory Meniere' s disease.
    Ren H; Yin T; Lu Y; Kong W; Ren J
    Int J Clin Exp Med; 2015; 8(4):6016-23. PubMed ID: 26131198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the therapeutic potential of intravenous glycerol for Meniere's disease: Robust results from an extensive patient cohort.
    Scarpa A; Carucci M; Salzano G; Avallone E; Cassandro C; De Luca P; Chiarella G; Ricciardiello F; Ralli M; Viola P; Salzano FA
    Am J Otolaryngol; 2024; 45(1):104093. PubMed ID: 37924560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menière's disease.
    Wright T
    BMJ Clin Evid; 2015 Nov; 2015():. PubMed ID: 26545070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratympanic Therapies for Menière's disease.
    Miller MW; Agrawal Y
    Curr Otorhinolaryngol Rep; 2014 Sep; 2(3):137-143. PubMed ID: 25215266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic corticosteroids in Ménière's disease: A mini-review.
    Patel M
    J Otol; 2017 Sep; 12(3):117-124. PubMed ID: 29937846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo effect in randomized controlled trials for Meniere's disease: A meta-analysis.
    Taniguchi AN; Sutton SR; Mills JF; Nguyen SA; Rizk HG; Meyer TA; Nguyen JP; Lambert PR
    Am J Otolaryngol; 2024; 45(2):104178. PubMed ID: 38101129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic dexamethasone application in Meniere's disease-Is it superior to conventional therapy?
    Paragache G; Panda NK; Ragunathan M; Sridhara
    Indian J Otolaryngol Head Neck Surg; 2005 Jan; 57(1):21-3. PubMed ID: 23120117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Term Outcomes of Intratympanic Dexamethasone in Intractable Unilateral Meniere's Disease.
    Pradhan P; Lal P; Sen K
    Indian J Otolaryngol Head Neck Surg; 2019 Nov; 71(Suppl 2):1369-1373. PubMed ID: 31750179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of vestibular neurotomy in disabling Ménière's disease and Tumarkin drop attacks.
    Véleine Y; Brenet E; Labrousse M; Chays A; Bazin A; Kleiber JC; Dubernard X
    J Neurosurg; 2022 Oct; 137(4):1034-1040. PubMed ID: 34996039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of different methylprednisolone administration routes in patients with sudden hearing loss or Meniere's disease.
    Chen D; Li Z; Zhou Q; Chen Y; Yang L; Tan J; Zeng X; Li P
    J Otol; 2020 Dec; 15(4):149-154. PubMed ID: 33293916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Recovery after Vestibular Schwannoma Excision with Intratympanic Gentamicin Prehabilitation.
    Trudel M; Stapleton EJ; Wadeson AM; Spiller W; North HJ; Heal C; Sebastian J; Freeman SR; Rutherford SA; Entwistle H; Hammerbeck-Ward CL; Pathmanaban O; King AT; Lloyd SKW
    Laryngoscope; 2024 Jul; 134(7):3316-3322. PubMed ID: 38332515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.